UB Paderborn / Katalog / Suche / in CDI

Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers

Cancer cell, 2015-09, Vol.28 (3), p.384-398

2015

Volltextzugriff (PDF)

Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling

Particle and fibre toxicology, 2009-01, Vol.6 (1), p.1-1, Article 1

2009

Volltextzugriff (PDF)

Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis

Molecular cancer therapeutics, 2021-07, Vol.20 (7), p.1234-1245

2021

Volltextzugriff (PDF)

Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models

Neuro-oncology (Charlottesville, Va.), 2016-09, Vol.18 (9), p.1230-1241

2016

Volltextzugriff (PDF)

Worldwide Prevalence of Mandibular Second Molar C-Shaped Morphologies Evaluated by Cone-Beam Computed Tomography

Journal of endodontics, 2017-09, Vol.43 (9), p.1442-1447

2017

Volltextzugriff (PDF)

A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer

Molecular cancer therapeutics, 2020-02, Vol.19 (2), p.460-467

2020

Volltextzugriff (PDF)

Short Stature, Accelerated Bone Maturation, and Early Growth Cessation Due to Heterozygous Aggrecan Mutations

The journal of clinical endocrinology and metabolism, 2014-08, Vol.99 (8), p.E1510-E1518

2014

Volltextzugriff (PDF)

Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages

Molecular cancer therapeutics, 2021-11, Vol.20 (11), p.2098-2109

2021

Volltextzugriff (PDF)

Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT)

Bioorganic & medicinal chemistry letters, 2022-10, Vol.74, p.128928-128928, Article 128928

2022

Volltextzugriff (PDF)

Genitourinary defects associated with genomic deletions in 2p15 encompassing OTX1

PloS one, 2014-09, Vol.9 (9), p.e107028

2014

Volltextzugriff (PDF)

Dialectical behaviour therapy for treating adults and adolescents with emotional and behavioural dysregulation: study protocol of a coordinated implementation in a publicly funded health service

BMC psychiatry, 2018-02, Vol.18 (1), p.51-51, Article 51

2018

Volltextzugriff (PDF)

Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors

Bioorganic & medicinal chemistry letters, 2022-10, Vol.74, p.128929-128929, Article 128929

2022

Volltextzugriff (PDF)

Individuals who report having benefitted from dialectical behaviour therapy (DBT): a qualitative exploration of processes and experiences at long-term follow-up

Borderline personality disorder and emotion dysregulation, 2022-03, Vol.9 (1), p.8-8, Article 8

2022

Volltextzugriff (PDF)

Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors

American journal of hematology, 2012-11, Vol.87 (11), p.E125-E128

2012

Volltextzugriff (PDF)

Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia

Haematologica (Roma), 2017-03, Vol.102 (3), p.519

2017

Volltextzugriff (PDF)

Discovery of 1‑(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3‑d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells

Journal of medicinal chemistry, 2015-05, Vol.58 (10), p.4165-4179

2015

Volltextzugriff (PDF)

Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2

Molecular cancer therapeutics, 2015-09, Vol.14 (9), p.2023-2034

2015

Volltextzugriff (PDF)

Wound Healing and Cancer Stem Cells: Inflammation as a Driver of Treatment Resistance in Breast Cancer

Cancer Growth and Metastasis, 2015-01, Vol.2015 (2015), p.1-13

2015

Volltextzugriff (PDF)

G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells

American Journal of Physiology: Cell Physiology, 2004-08, Vol.287 (2), p.C281-C291

2004

Volltextzugriff (PDF)

Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung Cancer

Clinical cancer research, 2008-12, Vol.14 (24), p.8213-8220

2008

Volltextzugriff (PDF)

Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma

Neoplasia (New York, N.Y.), 2011, Vol.13 (1), p.12-IN2

2011

Volltextzugriff (PDF)

Ultrafast Optical Excitations In Supramolecular Metallacycles with Charge Transfer Properties

Journal of the American Chemical Society, 2010-02, Vol.132 (4), p.1348-1358

2010

Volltextzugriff (PDF)

Evaluating the national multisite implementation of dialectical behaviour therapy in a community setting: a mixed methods approach

BMC psychiatry, 2020-05, Vol.20 (1), p.235-235, Article 235

2020

Volltextzugriff (PDF)

Dialectical behaviour therapy skills reconsidered: applying skills training to emotionally dysregulated individuals who do not engage in suicidal and self-harming behaviours

Borderline personality disorder and emotion dysregulation, 2020-01, Vol.7 (1), p.3-3, Article 3

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers

Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling

Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis

Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models

Worldwide Prevalence of Mandibular Second Molar C-Shaped Morphologies Evaluated by Cone-Beam Computed Tomography

A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer

Short Stature, Accelerated Bone Maturation, and Early Growth Cessation Due to Heterozygous Aggrecan Mutations

Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages

Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT)

Genitourinary defects associated with genomic deletions in 2p15 encompassing OTX1

Dialectical behaviour therapy for treating adults and adolescents with emotional and behavioural dysregulation: study protocol of a coordinated implementation in a publicly funded health service

Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors

Individuals who report having benefitted from dialectical behaviour therapy (DBT): a qualitative exploration of processes and experiences at long-term follow-up

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors

Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia

Discovery of 1‑(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3‑d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells

Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2

Wound Healing and Cancer Stem Cells: Inflammation as a Driver of Treatment Resistance in Breast Cancer

G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells

Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung Cancer

Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma

Ultrafast Optical Excitations In Supramolecular Metallacycles with Charge Transfer Properties

Evaluating the national multisite implementation of dialectical behaviour therapy in a community setting: a mixed methods approach

Dialectical behaviour therapy skills reconsidered: applying skills training to emotionally dysregulated individuals who do not engage in suicidal and self-harming behaviours

Suchergebnisse filtern